beta-lactams has been researched along with zidovudine in 1 studies
Studies (beta-lactams) | Trials (beta-lactams) | Recent Studies (post-2010) (beta-lactams) | Studies (zidovudine) | Trials (zidovudine) | Recent Studies (post-2010) (zidovudine) |
---|---|---|---|---|---|
7,579 | 179 | 3,395 | 10,180 | 1,399 | 1,188 |
Protein | Taxonomy | beta-lactams (IC50) | zidovudine (IC50) |
---|---|---|---|
Thymidine kinase, cytosolic | Homo sapiens (human) | 3 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.6633 | |
Protease | Human immunodeficiency virus 1 | 0.015 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Carretero, E; Docquier, JD; Feller, G; Gavara, L; Lari, L; Licznar-Fajardo, P; Rosales-Hurtado, M; Sannio, F; Verdirosa, F; Vo-Hoang, Y | 1 |
1 other study(ies) available for beta-lactams and zidovudine
Article | Year |
---|---|
Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Gram-Negative Bacteria; Prodrugs; Zidovudine | 2023 |